« Back to Record
Citation APA

Sotiriou, C., Loi, S., Haibe-Kains, B., Lallemand, F., Pusztai, L., Bardelli, A., Bedard, P. L., Gillet, C., Ellis, P., Phillips, W., Piccart-Gebhart, M., & McArthur, G. A. (2009). PIK3CA mutation-associated gene expression signature correlates with deactivation of the PI3K pathway and predicts benefit to endocrine therapy in high-risk ER+ (luminal B) breast cancers (BC). Proc Am Assoc Cancer Res. Abstract session presented at AACR Annual meeting(April 2009: Denver, Co, USA)


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/159286

Sotiriou, C., Loi, S., Haibe-Kains, B., Lallemand, F., Pusztai, L., Bardelli, A., Bedard, P. L., Gillet, C., Ellis, P., Phillips, W., Piccart-Gebhart, M., & McArthur, G. A. (2009). PIK3CA mutation-associated gene expression signature correlates with deactivation of the PI3K pathway and predicts benefit to endocrine therapy in high-risk ER+ (luminal B) breast cancers (BC). Proc Am Assoc Cancer Res. Abstract session presented at AACR Annual meeting(April 2009: Denver, Co, USA)